Announcements Trials
Browse Landscape

Phase

Phase 2 7

Status

Unknown 7Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Breast Neoplasms 1476Neoplasms 999Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 647Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 292Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

lenvatinib 3tislelizumab 2theasinensin A 1sitravatinib 1sintilimab 1S 1 (combination) 1Gemcitabine 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × OTHER × Advanced Biliary Tract Cancer × Clear all
NCT04727996 2024-04-19

BTC-BGB

Seoul National University Hospital

Phase 2 Unknown
43 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT05820906 2023-12-06

Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT05812430 2023-09-13

Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Unknown
20 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT05823987 2023-06-27

OPTIONS-05

Fudan University

Phase 2 Unknown
25 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT05781074 2023-03-24

CASTLE-08

Fudan University

Phase 2 Unknown
25 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT05410197 2022-10-12

Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)

Sun Yat-sen University

Phase 2 Unknown
43 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT04027764 2019-07-22

Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

Chinese PLA General Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡